Results 221 to 230 of about 38,144 (289)

Real‐world hepatitis C prevalence and treatment uptake at opioid agonist therapy clinics in Ontario, Canada [PDF]

Brett Wolfson‐Stofko, Grishma Hirode, Aaron Vanderhoff, Joel Karkada, Camelia Capraru, Maurizio Biondi, Bettina E. Hansen, Hemant Shah, Harry L.A. Janssen, Jordan J. Feld   +9 more
openalex   +1 more source

Comparative effectiveness of alternative initial doses of opioid agonist treatment for individuals with opioid use disorder: a protocol for a retrospective population-based study using target trial emulation in British Columbia, Canada. [PDF]

BMJ Open
Yan R, Hossain MB, Min JE, Kurz M, Smith K, Piske M, Seaman S, Bach P, Karim E, Platt RW, Siebert U, Socías ME, Xie H, Nosyk B.   +13 more
europepmc   +1 more source

Glucagon-like peptide-1 receptor agonists for the treatment of opioid use disorders: a systematic review [PDF]

Hezekiah C.T. Au, Rex Pui Kin Lam, Farah Kabir, Chen Huang, Christine E. Dri, Gia Han Le, Angela T.H. Kwan, Sabrina Wong, Kayla M. Teopiz, Roger S. McIntyre   +9 more
openalex   +1 more source

The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review. [PDF]

BMC Psychiatry
Hestevik CH, Evensen LH, Kornør H, Skeie I.   +3 more
europepmc   +1 more source

Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study. [PDF]

Addiction
Santo TJ, Chaillon A, Martin N, Hickman M, Jones N, Farrell M, Bharat C, Degenhardt L, Borquez A.   +8 more
europepmc   +1 more source

Cochrane in CORR® : Opioid Agonist Treatment for People Who are Dependent on Pharmaceutical Opioids. [PDF]

Clin Orthop Relat Res
Madden K.
europepmc   +1 more source

Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment. [PDF]

Drug Alcohol Rev
Kypri K, Austin E, Jackson M, Wright K, Shui A, Li A, Sathasivam V, Bonevski B, Dunlop AJ.   +8 more
europepmc   +1 more source

Universal Health Coverage of Opioid Agonist Treatment in Norway: An Equity-Adjusted Economic Evaluation. [PDF]

Pharmacoeconomics
Chaudhary P, Fadnes LT, Fosse S, Chalabianloo F, Johansson KA.   +4 more
europepmc   +1 more source

Interpersonal and structural dimensions of opioid agonist treatment stigma

Caruana, Theresa
openalex   +2 more sources

Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia's drug decriminalization policy: Insights from a provincial survey. [PDF]

Can J Public Health
Russell C, Law J, Hodgson K, MacKinnon L, Shahin R, Crichlow F, Patenaude S, Imtiaz S, Rehm J, Ali F.   +9 more
europepmc   +1 more source